Effects of pulsed electromagnetic therapy on the major hematological and biochemical parameters in horses.

Objective Overview

• This study investigates the short-term effects of pulsed electromagnetic field (PEMF) therapy on various blood-based hematological and biochemical parameters in sport horses.
• It aims to clarify the safety and physiological impact of PEMF therapy, which is increasingly used in the equine industry but lacks consistent scientific evaluation.

Introduction to PEMF Therapy in Horses

• Definition and Usage: Pulsed electromagnetic field (PEMF) therapy involves exposure to electromagnetic fields delivered in pulses, often through devices such as therapeutic blankets.
• Common Applications: In horses, PEMF is used to improve circulation, reduce inflammation, and promote cellular repair.
• Research Gap: Despite increasing popularity, there is a lack of definitive scientific evidence regarding the therapy’s effectiveness and safety in horses.

Study Design

• Subjects: Five active sport horses involved in regular exercise.
• Intervention: Horses received whole-body PEMF therapy daily for five consecutive days using a full-body blanket delivering electromagnetic pulses at specified frequencies.
• Data Collection: Blood samples were taken before and after the treatment period to measure 72 different hematological, biochemical, and endocrine markers.
• Parameters Analyzed: Key markers included reticulocytes, platelets, hemoglobin, plasma proteins, bilirubin, uric acid, creatine kinase, creatinine, liver enzymes, iron-binding capacity, cortisol, and thyroxine.
• Data Analysis: Pre- and post-therapy data were compared to identify any statistically significant changes.

Results and Observations

• Hematological Parameters:
  • Most parameters remained stable after PEMF therapy.
  • Significant increases or changes were observed in reticulocyte counts (immature red blood cells), platelet counts, and hemoglobin levels.
• Biochemical Parameters:
  • More variation was noted across markers in blood chemistry.
  • Notable changes were documented in plasma proteins (which influence osmotic pressure and immune response), bilirubin (a marker related to liver function), uric acid (a product of purine metabolism), creatine kinase (an enzyme related to muscle activity or damage), creatinine (kidney function marker), liver enzymes, and iron-binding capacity.
• Endocrine Parameters:
  • No significant alterations were found in cortisol (stress hormone) or thyroxine (thyroid hormone), suggesting that PEMF therapy did not provoke stress or disrupt thyroid function over the treatment period.

Interpretation of Findings

• Safety: The absence of adverse effects in health or stress markers suggests PEMF therapy is safe when applied short-term in sport horses.
• Physiological Impact: The significant changes in biochemical and hematological parameters indicate that PEMF may induce physiological responses that support cellular repair, circulation, or metabolism.
• Clinical Implications: Changes in parameters such as reticulocytes and platelets could indicate enhanced blood cell turnover or regeneration processes.
• Limitations: The study’s small sample size (five horses) and short duration (five days) limit the generalizability and long-term conclusions.
• Future Directions: Additional research is needed to elucidate the mechanisms by which PEMF alters blood parameters and to determine optimal protocols for therapy in equine practice.

Conclusions

• Whole-body PEMF therapy applied across five days does not negatively affect overall health or stress markers in sport horses.
• Observed significant changes in certain hematological and biochemical factors suggest beneficial physiological effects potentially related to repair and metabolism.
• The results support further investigation into the therapeutic uses and biological mechanisms of PEMF in equine health management.